Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Clinical Rheumatology|November 7, 2008
Pregnancy and rheumatic disease: "by the book" or "by the doc"Stephanie O Keeling, Anna E Oswald
Clinical Rheumatology|April 20, 2011
Lack of cardiovascular risk assessment in inflammatory arthritis and systemic lupus erythematosus patients at a tertiary care centerStephanie O Keeling, Michelle Teo, Daisy Fung
Immunotherapy|August 15, 2018
Subcutaneous belimumab in the treatment of systemic lupus erythematosusOfir Elalouf, Stephanie O Keeling, Zahi Touma
The Journal of Rheumatology|May 3, 2019
A Population-level Analysis of the Differing Effects of Rheumatoid Arthritis and Spondyloarthritis on Peripartum OutcomesStephanie O Keeling, Samantha L Bowker, Anamaria Savu, et al.
Clinical Rheumatology|May 28, 2017
Clinical effectiveness and safety of leflunomide in inflammatory arthritis: a report from the RAPPORT database with supporting patient surveyMorgan Schultz, Stephanie O Keeling, Steven J Katz, et al.
The Journal of Rheumatology|February 17, 2012
Preliminary validation of a self-reported screening questionnaire for inflammatory back painStephanie O Keeling, Sumit R Majumdar, Barbara Conner-Spady, et al.
The Journal of Rheumatology|August 17, 2018
Measuring Disease Activity and Damage with Validated Metrics: A Systematic Review on Mortality and Damage in Systemic Lupus ErythematosusStephanie O Keeling, Ben Vandermeer, Jorge Medina, et al.
The Journal of Rheumatology|August 3, 2018
Practice Variations in the Diagnosis, Monitoring, and Treatment of Systemic Lupus Erythematosus in CanadaStephanie O Keeling, Asvina Bissonauth, Sasha Bernatsky, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 6, 2024
Features of Axial Spondyloarthritis in Two Multicenter Cohorts of Patients with Psoriasis, Uveitis, and Colitis Presenting with Undiagnosed Back PainWalter P Maksymowych, Raj Carmona, Ulrich Weber, et al.
The Journal of Rheumatology|March 9, 2007
Testing of the preliminary OMERACT validation criteria for a biomarker to be regarded as reflecting structural damage endpoints in rheumatoid arthritis clinical trials: the example of C-reactive proteinStephanie O Keeling, Robert Landewe, Desiree van der Heijde, et al.
Pageof 2